Article
Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia.
Schizophrenia research - 1 Dec 2014
Wonodi Ikwunga, McMahon Robert P, Krishna Nithin, Mitchell Braxton D, Liu Judy, Glassman Matthew, Hong L Elliot, Gold James M
Abstract excerpt
BACKGROUND: Cognitive deficits compromise quality of life and productivity for individuals with schizophrenia and have no effective treatments. Preclinical data point to the kynurenine pathway of tryptophan metabolism as a potential target for pro-cognitive drug development. We have previously demonstrated association of a kynurenine 3-monooxygenase (KMO) gene variant with reduced KMO gene expression in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
